• TH287 MTH1 Inhibitor for Cancer Radiosensitization

  2026-09-11

  TH287 converts oxidized nucleotide stress into a measurable cancer-cell vulnerability and offers a practical way to model radiosensitization in CRPC cells. The reference study highlights a time-sensitive workflow: irradiation 12 hours after TH287 exposure produced stronger effects than later schedules in PC-3 and DU-145 cells.

• Cyanidin Chloride: An Evidence-First Research Guide

  2026-09-11

  Cyanidin Chloride can connect anthocyanin redox chemistry with cellular protection studies, but only when chemical identity and assay context are controlled. This evidence-first guide interprets recent skin-model findings, defines practical assay decisions, and clarifies what the data do—and do not—establish.

• Triamcinolone: Practical Research Protocol Guidance

  2026-09-10

  Triamcinolone is a research-grade synthetic glucocorticoid agonist for controlled studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses solubilization, storage, controls, and quality checks, while excluding clinical use and literature-derived dosing claims not supported by the available product dossier.

• Cy5 maleimide (non-sulfonated): Labeling Guide

  2026-09-10

  Cy5 maleimide (non-sulfonated) provides mono-reactive, cysteine-directed fluorescent labeling for proteins and peptides when an accessible thiol is available. Its low aqueous solubility requires preparation in DMSO or ethanol, so it is less suitable for workflows that cannot tolerate an organic co-solvent or that require non-thiol conjugation.

• (-)-Arctigenin in TAM–NF-κB Assay Design

  2026-09-09

  (-)-Arctigenin offers a mechanistically useful perturbation tool for testing macrophage–tumor signaling. This article translates breast cancer extracellular-vesicle findings into a rigorous assay strategy while separating evidence from hypothesis.

• Artesunate Workflows for Quantitative Cancer Assays

  2026-09-09

  Artesunate enables a more informative cancer-response workflow when viability, proliferation, and cell death are measured as distinct outcomes. This guide translates a quantitative in vitro framework into practical dosing, time-course, ferroptosis-oriented, and troubleshooting strategies for small cell lung carcinoma and esophageal squamous cell carcinoma research.

• DMG-PEG2000-NH2 in Translational LNP Design

  2026-09-08

  DMG-PEG2000-NH2 is an NH2-PEG derivative that connects lipid nanoparticle chemistry with assay-informed therapeutic design. This article explains how its amine-reactive architecture can support bioconjugation while clarifying the evidence, controls, and limitations involved in translating anti-TB discovery research into delivery workflows.

• Dlin-MC3-DMA LNP Workflow for RNA Delivery

  2026-09-08

  Learn how to use Dlin-MC3-DMA as a pH-responsive ionizable cationic liposome for reproducible siRNA and mRNA nanoparticle development. This bench-focused guide connects formulation parameters, machine-learning-guided screening, hepatic gene silencing, and troubleshooting decisions.

• Protoporphyrin IX: Heme and Photodynamic Research

  2026-09-07

  Protoporphyrin IX is a photodynamic compound and the final intermediate before heme formation. Its chemical properties support heme-biosynthesis, photodynamic cancer diagnosis, and photodynamic therapy research, but the cited HCC ferroptosis study does not directly test this molecule.

• Cy5 NHS ester(Et): Practical Labeling Guide

  2026-09-07

  Cy5 NHS ester(Et) provides a water-soluble NHS-ester route for covalently tagging primary amines in proteins, peptides, and related biomolecules. It is suited to fresh protein fluorescent labeling, immunofluorescence staining, flow cytometry, and fluorescence microscopy workflows, but should not be prepared in ethanol or kept as a long-term solution.

• Removing Pollen Interference in Bioaerosol Spectra

  2026-09-05

  Zhang and colleagues show that fluorescence features from pollen can complicate hazardous bioaerosol classification, but targeted spectral transformations combined with random forest analysis can substantially improve discrimination. Fast Fourier transform processing produced a reported accuracy of 89.24%, supporting rapid screening strategies while highlighting the need for broader validation under field conditions.

• Gepotidacin BA1220: Reliable Antibacterial Assays

  2026-09-04

  A scenario-driven guide to using Gepotidacin (SKU BA1220) in bacterial viability, proliferation, and antibiotic resistance research. It connects mechanism, solvent compatibility, concentration selection, interpretation of MIC data, and practical product-selection criteria to improve assay consistency.

• Gap19: Selective Cx43 Hemichannel Blocker Workflows

  2026-09-04

  Gap19 enables researchers to separate Cx43 hemichannel signaling from gap junction communication in astrocyte, ischemia, and inflammatory macrophage assays. This practical guide translates its reported neuroprotective and Cx43/NF-κB activity into dose-finding, control, and troubleshooting workflows.

• Necrostatin 2 (Nec-2) Experimental Workflow

  2026-09-03

  Necrostatin 2 (Nec-2) provides a practical chemical perturbation for testing whether loss of viability reflects RIPK2-associated necroptosis rather than irreversible membrane injury. This workflow connects necroptosis inhibition with infection, membrane-repair, and ischemic stroke research while emphasizing controls that prevent overinterpretation.

• PF-562271 HCl: FAK/Pyk2 Assay Workflow

  2026-09-03

  Build a controlled FAK/Pyk2 inhibition workflow around PF-562271 HCl for phosphorylation, adhesion, migration, and tumor-model studies. The approach also shows how to connect mechanistic assays with the multimodal imaging and pathology signals reported in gastric cancer immunotherapy research.

8071 records 1/539 page Next 12345 下5页 Last page